Nonpathogenic enteric protozoa - UpToDate
Nonpathogenic enteric protozoa
Nonpathogenic enteric protozoa
Authors:
Peter F Weller, MD, MACP
Karin Leder, MBBS, FRACP, PhD, MPH, DTMH
Section Editor:
Edward T Ryan, MD, DTMH
Deputy Editor:
Milana Bogorodskaya, MD
Literature review current through: Apr 2024.
This topic last updated: Oct 23, 2023.

INTRODUCTION

Several nonpathogenic protozoa inhabit the intestinal tract and may be identified in stool specimens sent to the clinical laboratory for ova and parasite examination [1]. Since these nonpathogenic parasites can be reported by the diagnostic laboratory, it is important to be able to distinguish between organisms that require treatment and organisms that do not.

The classification of nonpathogenic protozoa will be reviewed here. Several other enteric organisms, including Blastocystis hominis and Dientamoeba fragilis, are discussed separately. (See "Blastocystis species" and "Dientamoeba fragilis".)

NONPATHOGENIC PROTOZOA

The nonpathogenic protozoa can be divided into two groups: amebae and flagellates. The nonpathogenic amebae include:

Endolimax nana

Entamoeba bangladeshi

Disclaimer: This generalized information is a limited summary of diagnosis, treatment, and/or medication information. It is not meant to be comprehensive and should be used as a tool to help the user understand and/or assess potential diagnostic and treatment options. It does NOT include all information about conditions, treatments, medications, side effects, or risks that may apply to a specific patient. It is not intended to be medical advice or a substitute for the medical advice, diagnosis, or treatment of a health care provider based on the health care provider's examination and assessment of a patient's specific and unique circumstances. Patients must speak with a health care provider for complete information about their health, medical questions, and treatment options, including any risks or benefits regarding use of medications. This information does not endorse any treatments or medications as safe, effective, or approved for treating a specific patient. UpToDate, Inc. and its affiliates disclaim any warranty or liability relating to this information or the use thereof. The use of this information is governed by the Terms of Use, available at https://www.wolterskluwer.com/en/know/clinical-effectiveness-terms. 2024© UpToDate, Inc. and its affiliates and/or licensors. All rights reserved.
Loading
Please wait